537253 — Sunil Healthcare Income Statement
0.000.00%
- IN₹769.11m
- IN₹1.35bn
- IN₹901.92m
- 14
- 51
- 53
- 31
Annual income statement for Sunil Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 700 | 903 | 1,192 | 1,105 | 902 |
Cost of Revenue | |||||
Gross Profit | 414 | 476 | 707 | 633 | 438 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 805 | 911 | 1,081 | 1,013 | 920 |
Operating Profit | -105 | -7.63 | 111 | 91.5 | -18.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -30 | -5.53 | 92.6 | 94.8 | -25.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -23.7 | -6.38 | 64.2 | 66.8 | -17.8 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -49.6 | -6.38 | 64.2 | 66.8 | -17.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -49.6 | -6.38 | 64.2 | 66.8 | -17.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.14 | -0.584 | 6.26 | 6.45 | -1.63 |